Status:
RECRUITING
Effectiveness of Phenazopyridine for Pain Following Urodynamics
Lead Sponsor:
University of South Florida
Conditions:
Pain After Urodynamic Testing
Eligibility:
FEMALE
18-99 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
Eligibility Criteria
Inclusion
- ability to provide informed consent
- ability to complete visual analog scale
- requiring urodynamic testing
- 18 years of age or older
- must be able to read and write in English or Spanish
Exclusion
- allergy to phenazopyridine
- a urinary tract infection in the prior 2 weeks
- women who did not undergo urodynamic testing
- patient less than 18 years old
- patients with known (noted in patient chart and verbally asked) severe renal insufficiency with GFR \<50 mL/min,
- patients with known (noted in patient chart and verbally asked) severe hepatitis
- patients with known (noted in patient chart and verbally asked) G6PD deficiency
- history of fibromyalgia
- history of interstitial cystitis
- non English or Spanish speaking
Key Trial Info
Start Date :
December 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06577493
Start Date
December 17 2024
End Date
July 1 2025
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida South Tampa Center
Tampa, Florida, United States, 33606